A Workflow to Achieve Saturation of Fluorophore‐Conjugated Monoclonal Antibodies for Robust Comparison of Biomarker Expression
ABSTRACT Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents shoul...
Saved in:
Published in | Cytometry. Part A Vol. 107; no. 6; pp. 378 - 389 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.06.2025
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT
Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore‐labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore‐conjugated mAbs, by ‘spiking‐in’ unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti‐CD3 (clone OKT3, mouse IgG2a) and anti‐TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2‐fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore‐labeled anti‐mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then ‘spiked’ into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions. |
---|---|
AbstractList | Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore-labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore-conjugated mAbs, by 'spiking-in' unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti-CD3 (clone OKT3, mouse IgG2a) and anti-TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2-fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore-labeled anti-mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then 'spiked' into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions. ABSTRACT Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore‐labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore‐conjugated mAbs, by ‘spiking‐in’ unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti‐CD3 (clone OKT3, mouse IgG2a) and anti‐TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2‐fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore‐labeled anti‐mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then ‘spiked’ into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions. Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore-labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore-conjugated mAbs, by 'spiking-in' unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti-CD3 (clone OKT3, mouse IgG2a) and anti-TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2-fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore-labeled anti-mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then 'spiked' into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions.Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible results. When aiming to compare antigen expression between samples using mean or median fluorescence intensity (MFI), reagents should be used at a saturating concentration so that unavoidable variations in staining conditions do not affect the fluorescence signal. The recommended concentrations of commercially available fluorophore-labeled monoclonal antibodies (mAbs) may not achieve plateau staining, and their saturating concentration may be too high to be experimentally useful. To address these common concerns, we present a novel method to achieve saturation of fluorophore-conjugated mAbs, by 'spiking-in' unlabelled antibody of the same clone. Here, we demonstrate the application of this workflow to human anti-CD3 (clone OKT3, mouse IgG2a) and anti-TCRαβ (clone IP26, mouse IgG1), two mAbs that do not achieve saturation at 2-fold above their commercially recommended concentrations. First, the saturating concentration of unlabelled (purified) OKT3 and IP26 was determined by detection with a fluorophore-labeled anti-mouse IgG (H + L) secondary antibody. Titration curves of unlabelled and labeled mAbs were compared for each clone to determine whether labeling had resulted in any loss in binding activity. Unlabelled antibody was then 'spiked' into the labeled antibody at varying ratios, and those that achieved saturation while maintaining an adequate fluorescence signal were identified. We demonstrate that antibody saturation can be achieved with an optimized mixture of labeled and unlabelled antibody, while maintaining a clear signal from the fluorophore. While this workflow has only been applied to OKT3 and IP26, it has potential applicability for any antibody clone for which both labeled and unlabelled preparations are available. This method has significance for robust comparison of biomarker expression when fluorophore labeled reagents do not reach saturation under standard staining conditions. |
Author | McGuire, Helen Smith, Natalie Fazekas de St Groth, Barbara |
Author_xml | – sequence: 1 givenname: Natalie orcidid: 0000-0002-9186-2719 surname: Smith fullname: Smith, Natalie email: natalie.smith1@sydney.edu.au organization: The University of Sydney – sequence: 2 givenname: Helen orcidid: 0000-0003-2047-6543 surname: McGuire fullname: McGuire, Helen organization: The University of Sydney – sequence: 3 givenname: Barbara orcidid: 0000-0001-6817-9690 surname: Fazekas de St Groth fullname: Fazekas de St Groth, Barbara organization: The University of Sydney |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40298242$$D View this record in MEDLINE/PubMed |
BookMark | eNp90T1v1TAUBmALFdEP2JiRJRYG7sVfcZIxRG1BKqoERYjJcpwT6tvcnGAnlLv1J_Q38ktwSenAwOQzPOeVjt9DsjfgAIQ852zNGRNv3G7CtV0LVcriETngWSZWaWZ7D7MQ--Qwxg1jMmNSPCH7iomyEEockJuKfsFw1fV4TSeklbv08APoJzvNwU4eB4odPelnDDheYoBfN7c1Dpv5m52gpR9wQNfjYHtaDZNvsPUQaYeBfsRmjhOtcTva4OOS89bj1oYrCPT45xggxpT_lDzubB_h2f17RD6fHF_U71Zn56fv6-ps5aTmxSrnqtUNZC2XBYM8c4LnjHety6BxjbAaGNd5KQVrS6s164RQnWWCyVKDbJQ8Iq-W3DHg9xniZLY-Ouh7OwDO0Uheas0zJfNEX_5DNziHdGRSQpS5YnleJPXiXs3NFlozBp-O25m_f5vA6wW4gDEG6B4IZ-auOnNXnbHmT3WJq4Vf-x52_7Wm_npxXi1rvwErHJ5s |
Cites_doi | 10.1016/S0090-8258(03)00009-X 10.7554/eLife.04333 10.1002/cpz1.589 10.1002/cyto.b.20158 10.1002/cyto.b.22155 10.1093/clinchem/31.8.1264 10.1002/(sici)1097‐0320(19980601)32:23.0.co;2‐g 10.1080/00032719608001447 10.1002/0471142956.cy0629s54 10.1002/ijc.24137 10.1002/ijc.2910610605 10.1111/j.1365-2257.1996.tb00728.x 10.1172/JCI1457 10.1007/978-1-0716-2217-9_4 10.3892/ol.2016.4209 10.1016/0008-8749(92)90321-F 10.1111/j.1365-2141.2000.02415.x 10.1182/blood.V88.9.3513.bloodjournal8893513 10.1002/cyto.a.21147 10.1042/BSR20203827 10.1038/483531a 10.1155/2020/1039458 10.1038/nprot.2006.268 10.1016/0161-5890(85)90029-X 10.1002/eji.202170126 10.3390/cells13201677 10.1002/cyto.a.20092 10.1016/0022-1759(86)90072-4 |
ContentType | Journal Article |
Copyright | 2025 The Author(s). published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry. 2025 The Author(s). Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry. 2025. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2025 The Author(s). published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry. – notice: 2025 The Author(s). Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry. – notice: 2025. This work is published under Creative Commons Attribution License~https://creativecommons.org/licenses/by/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7TK 8FD FR3 P64 7X8 |
DOI | 10.1002/cyto.a.24938 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef Engineering Research Database |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1552-4930 |
EndPage | 389 |
ExternalDocumentID | 40298242 10_1002_cyto_a_24938 CYTOA24938 |
Genre | researchArticle Journal Article |
GrantInformation_xml | – fundername: an Australian Government Research Training Program (RTP) – fundername: National Health and Medical Research Council funderid: 2014538 – fundername: National Health and Medical Research Council grantid: 2014538 |
GroupedDBID | --- -~X .3N .GA .Y3 05W 0R~ 10A 1L6 1OC 24P 2WC 31~ 33P 3SF 4.4 4ZD 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHQN AAMMB AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABPVW ACAHQ ACCZN ACFBH ACGFS ACIWK ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGXDD AGYGG AHBTC AIDQK AIDYY AITYG AIURR AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CO8 CS3 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRSTM DU5 E3Z EBD EBS EJD EMOBN F00 F01 F04 F5P G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 P2P P2W P2X P4D Q.N QB0 QRW R.K RNS ROL SUPJJ SV3 UB1 V2E W8V W99 WBKPD WIH WIK WIN WJL WNSPC WOHZO WQJ WXSBR WYISQ XG1 XV2 ZZTAW ~IA ~KM ~WT AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7TK 8FD FR3 P64 7X8 |
ID | FETCH-LOGICAL-c3618-714d6be5d1380e75c21701fdc5ebcb2a6e01679320d9a660f224fa020396e3b43 |
IEDL.DBID | DR2 |
ISSN | 1552-4922 1552-4930 |
IngestDate | Fri Jul 11 18:27:59 EDT 2025 Tue Jul 29 17:51:11 EDT 2025 Tue Jul 15 01:30:38 EDT 2025 Thu Jul 24 02:02:55 EDT 2025 Wed Jul 30 09:30:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | titration antibody saturation flow cytometry |
Language | English |
License | Attribution 2025 The Author(s). Cytometry Part A published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3618-714d6be5d1380e75c21701fdc5ebcb2a6e01679320d9a660f224fa020396e3b43 |
Notes | Funding This work was supported by National Health and Medical Research Council, 2014538. N. Smith is supported by an Australian Government Research Training Program (RTP) scholarship. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-9186-2719 0000-0003-2047-6543 0000-0001-6817-9690 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.24938 |
PMID | 40298242 |
PQID | 3229740778 |
PQPubID | 2045167 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_3196615437 proquest_journals_3229740778 pubmed_primary_40298242 crossref_primary_10_1002_cyto_a_24938 wiley_primary_10_1002_cyto_a_24938_CYTOA24938 |
PublicationCentury | 2000 |
PublicationDate | June 2025 |
PublicationDateYYYYMMDD | 2025-06-01 |
PublicationDate_xml | – month: 06 year: 2025 text: June 2025 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Hoboken |
PublicationTitle | Cytometry. Part A |
PublicationTitleAlternate | Cytometry A |
PublicationYear | 2025 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2010; 54 1986; 90 2012; 483 1996; 18 2022; 2475 2004; 62 2024; 106 1992; 145 2011; 79 2007; 72 2000; 111 2006; 1 2024; 13 1985; 22 1999; 5 2021; 51 2016; 11 1995; 61 2021; 10 1996; 29 2020; 2020 2014; 3 2001; 7 2009; 124 2001; 1 2022; 2 1998; 32 1996; 2 2021; 41 1985; 31 1998; 101 2003; 89 1996; 88 Kuss I. (e_1_2_11_6_1) 1999; 5 e_1_2_11_10_1 e_1_2_11_32_1 e_1_2_11_31_1 e_1_2_11_30_1 e_1_2_11_14_1 e_1_2_11_13_1 e_1_2_11_34_1 e_1_2_11_11_1 e_1_2_11_33_1 e_1_2_11_7_1 e_1_2_11_29_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_27_1 e_1_2_11_26_1 e_1_2_11_3_1 Kono K. (e_1_2_11_4_1) 1996; 2 Stewart C. C. (e_1_2_11_18_1) 2001; 1 Dworacki G. (e_1_2_11_2_1) 2001; 7 e_1_2_11_21_1 e_1_2_11_20_1 e_1_2_11_25_1 e_1_2_11_24_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_8_1 Errington T. M. (e_1_2_11_12_1) 2021; 10 e_1_2_11_22_1 e_1_2_11_17_1 e_1_2_11_16_1 e_1_2_11_15_1 e_1_2_11_19_1 |
References_xml | – volume: 7 start-page: 947s issue: S3 year: 2001 end-page: 957s article-title: Decreased Zeta Chain Expression and Apoptosis in CD3+ Peripheral Blood T Lymphocytes of Patients With Melanoma publication-title: Clinical Cancer Research – volume: 22 start-page: 11 issue: 1 year: 1985 end-page: 21 article-title: Kinetics of Divalent Monoclonal Antibody Binding to Tumour Cell Surface Antigens Using Flow Cytometry: Standardization and Mathematical Analysis publication-title: Molecular Immunology – volume: 11 start-page: 2199 issue: 3 year: 2016 end-page: 2206 article-title: Development of a Standardized Flow Cytometric Method to Conduct Longitudinal Analyses of Intracellular CD3zeta Expression in Patients With Head and Neck Cancer publication-title: Oncology Letters – volume: 145 start-page: 175 issue: 1 year: 1992 end-page: 186 article-title: The CD45RO (p180, UCHL1) Marker: Complexity of Expression in Peripheral Blood publication-title: Cellular Immunology – volume: 5 start-page: 329 issue: 2 year: 1999 end-page: 334 article-title: Clinical Significance of Decreased Zeta Chain Expression in Peripheral Blood Lymphocytes of Patients With Head and Neck Cancer publication-title: Clinical Cancer Research – volume: 111 start-page: 817 issue: 3 year: 2000 end-page: 825 article-title: Impaired Expression of the CD3‐Zeta Chain in Peripheral Blood T Cells of Patients With Chronic Myeloid Leukaemia Results in an Increased Susceptibility to Apoptosis publication-title: British Journal of Haematology – volume: 88 start-page: 3513 issue: 9 year: 1996 end-page: 3521 article-title: Heterogeneity of the Human CD4+ T‐Cell Population: Two Distinct CD4+ T‐Cell Subsets Characterized by Coexpression of CD45RA and CD45RO Isoforms publication-title: Blood – volume: 101 start-page: 1448 issue: 7 year: 1998 end-page: 1457 article-title: Altered Pattern of TCR/CD3‐Mediated Protein‐Tyrosyl Phosphorylation in T Cells From Patients With Systemic Lupus Erythematosus. Deficient Expression of the T Cell Receptor Zeta Chain publication-title: Journal of Clinical Investigation – volume: 90 start-page: 165 issue: 2 year: 1986 end-page: 172 article-title: Measurement of Tumour Reactive Antibody and Antibody Conjugate by Competition, Quantitated by Flow Cytofluorimetry publication-title: Journal of Immunological Methods – volume: 1 start-page: 1507 issue: 3 year: 2006 end-page: 1516 article-title: Intracellular Cytokine Optimization and Standard Operating Procedure publication-title: Nature Protocols – volume: 32 start-page: 109 issue: 2 year: 1998 end-page: 119 article-title: Impaired Expression and Function of Signal‐Transducing Zeta Chains in Peripheral T Cells and Natural Killer Cells in Patients With Prostate Cancer publication-title: Cytometry – volume: 62 start-page: 169 issue: 2 year: 2004 end-page: 173 article-title: Selecting Fluorochrome Conjugates for Maximum Sensitivity publication-title: Cytometry, Part A – volume: 61 start-page: 765 issue: 6 year: 1995 end-page: 772 article-title: Alterations in the Signal‐Transducing Molecules of T Cells and NK Cells in Colorectal Tumor‐Infiltrating, Gut Mucosal and Peripheral Lymphocytes: Correlation With the Stage of the Disease publication-title: International Journal of Cancer – volume: 2020 year: 2020 article-title: Defects at the Posttranscriptional Level Account for the Low TCRzeta Chain Expression Detected in Gastric Cancer Independently of Caspase‐3 Activity publication-title: Journal of Immunology Research – volume: 3 start-page: 3 year: 2014 article-title: An Open Investigation of the Reproducibility of Cancer Biology Research publication-title: eLife – volume: 2475 start-page: 61 year: 2022 end-page: 77 article-title: Absolute Quantification of Plasma Membrane Receptors via Quantitative Flow Cytometry publication-title: Methods in Molecular Biology – volume: 124 start-page: 1605 issue: 7 year: 2009 end-page: 1613 article-title: Mechanisms Involved in the Down‐Regulation of TCR Zeta Chain in Tumor Versus Peripheral Blood of Oral Cancer Patients publication-title: International Journal of Cancer – volume: 18 start-page: 1 issue: 1 year: 1996 end-page: 5 article-title: Use and Evaluation of Leucocyte Monoclonal Antibodies in the Diagnostic Laboratory: A Review publication-title: Clinical and Laboratory Haematology – volume: 51 start-page: 2708 issue: 12 year: 2021 end-page: 3145 article-title: Guidelines for the Use of Flow Cytometry and Cell Sorting in Immunological Studies (Third Edition) publication-title: European Journal of Immunology – volume: 79 start-page: 990 issue: 12 year: 2011 end-page: 999 article-title: Fluorescent Particles in the Antibody Solution Result in False TF‐ and CD14‐Positive Microparticles in Flow Cytometric Analysis publication-title: Cytometry. Part A – volume: 2 start-page: 1825 issue: 11 year: 1996 end-page: 1828 article-title: Decreased Expression of Signal‐Transducing Zeta Chain in Peripheral T Cells and Natural Killer Cells in Patients With Cervical Cancer publication-title: Clinical Cancer Research – volume: 54 start-page: 6 issue: 1 year: 2010 end-page: 29 article-title: Titration of Fluorochrome‐Conjugated Antibodies for Labeling Cell Surface Markers on Live Cells publication-title: Current Protocols in Cytometry – volume: 1 start-page: 1 year: 2001 end-page: 4 article-title: Titering Antibodies publication-title: Current Protocols in Cytometry – volume: 483 start-page: 531 issue: 7391 year: 2012 end-page: 533 article-title: Drug Development: Raise Standards for Preclinical Cancer Research publication-title: Nature – volume: 31 start-page: 1264 issue: 8 year: 1985 end-page: 1271 article-title: Guidelines for Immunoassay Data Processing publication-title: Clinical Chemistry – volume: 72 start-page: 223 issue: 3 year: 2007 end-page: 226 article-title: Statistical Criteria to Establish Optimal Antibody Dilution in Flow Cytometry Analysis publication-title: Cytometry Part B: Clinical Cytometry – volume: 106 start-page: 25 issue: 1 year: 2024 end-page: 34 article-title: Standardization of Flow Cytometric Detection of Antigen Expression publication-title: Cytometry. Part B, Clinical Cytometry – volume: 89 start-page: 120 issue: 1 year: 2003 end-page: 128 article-title: No Alteration in NK Function or Zeta Chain Expression in NK and T Cells of Cervical Cancer Patients publication-title: Gynecologic Oncology – volume: 10 start-page: 10 year: 2021 article-title: Investigating the Replicability of Preclinical Cancer Biology publication-title: eLife – volume: 13 issue: 20 year: 2024 article-title: The Power of Reagent Titration in Flow Cytometry publication-title: Cells – volume: 2 issue: 11 year: 2022 article-title: Do More With Less: Improving High Parameter Cytometry Through Overnight Staining publication-title: Current Protocols – volume: 29 start-page: 953 issue: 6 year: 1996 end-page: 968 article-title: Assessment of the Effect of Increased Fluorophore Labelling on the Binding Ability of an Antibody publication-title: Analytical Letters – volume: 41 issue: 2 year: 2021 article-title: Effects of Storage Time and Temperature on Highly Multiparametric Flow Analysis of Peripheral Blood Samples; Implications for Clinical Trial Samples publication-title: Bioscience Reports – ident: e_1_2_11_14_1 doi: 10.1016/S0090-8258(03)00009-X – ident: e_1_2_11_11_1 doi: 10.7554/eLife.04333 – ident: e_1_2_11_30_1 doi: 10.1002/cpz1.589 – volume: 2 start-page: 1825 issue: 11 year: 1996 ident: e_1_2_11_4_1 article-title: Decreased Expression of Signal‐Transducing Zeta Chain in Peripheral T Cells and Natural Killer Cells in Patients With Cervical Cancer publication-title: Clinical Cancer Research – ident: e_1_2_11_26_1 doi: 10.1002/cyto.b.20158 – ident: e_1_2_11_34_1 doi: 10.1002/cyto.b.22155 – ident: e_1_2_11_32_1 doi: 10.1093/clinchem/31.8.1264 – ident: e_1_2_11_3_1 doi: 10.1002/(sici)1097‐0320(19980601)32:23.0.co;2‐g – ident: e_1_2_11_22_1 doi: 10.1080/00032719608001447 – ident: e_1_2_11_17_1 doi: 10.1002/0471142956.cy0629s54 – volume: 7 start-page: 947s issue: 3 year: 2001 ident: e_1_2_11_2_1 article-title: Decreased Zeta Chain Expression and Apoptosis in CD3+ Peripheral Blood T Lymphocytes of Patients With Melanoma publication-title: Clinical Cancer Research – volume: 10 start-page: 10 year: 2021 ident: e_1_2_11_12_1 article-title: Investigating the Replicability of Preclinical Cancer Biology publication-title: eLife – ident: e_1_2_11_9_1 doi: 10.1002/ijc.24137 – ident: e_1_2_11_5_1 doi: 10.1002/ijc.2910610605 – ident: e_1_2_11_16_1 doi: 10.1111/j.1365-2257.1996.tb00728.x – ident: e_1_2_11_10_1 doi: 10.1172/JCI1457 – ident: e_1_2_11_33_1 doi: 10.1007/978-1-0716-2217-9_4 – ident: e_1_2_11_15_1 doi: 10.3892/ol.2016.4209 – ident: e_1_2_11_29_1 doi: 10.1016/0008-8749(92)90321-F – ident: e_1_2_11_7_1 doi: 10.1111/j.1365-2141.2000.02415.x – ident: e_1_2_11_28_1 doi: 10.1182/blood.V88.9.3513.bloodjournal8893513 – ident: e_1_2_11_31_1 doi: 10.1002/cyto.a.21147 – volume: 5 start-page: 329 issue: 2 year: 1999 ident: e_1_2_11_6_1 article-title: Clinical Significance of Decreased Zeta Chain Expression in Peripheral Blood Lymphocytes of Patients With Head and Neck Cancer publication-title: Clinical Cancer Research – ident: e_1_2_11_25_1 doi: 10.1042/BSR20203827 – ident: e_1_2_11_13_1 doi: 10.1038/483531a – ident: e_1_2_11_8_1 doi: 10.1155/2020/1039458 – volume: 1 start-page: 1 year: 2001 ident: e_1_2_11_18_1 article-title: Titering Antibodies publication-title: Current Protocols in Cytometry – ident: e_1_2_11_27_1 doi: 10.1038/nprot.2006.268 – ident: e_1_2_11_23_1 doi: 10.1016/0161-5890(85)90029-X – ident: e_1_2_11_19_1 doi: 10.1002/eji.202170126 – ident: e_1_2_11_20_1 doi: 10.3390/cells13201677 – ident: e_1_2_11_21_1 doi: 10.1002/cyto.a.20092 – ident: e_1_2_11_24_1 doi: 10.1016/0022-1759(86)90072-4 |
SSID | ssj0035032 |
Score | 2.4193518 |
Snippet | ABSTRACT
Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly... Antibody titration is an important step in every cytometric workflow, with the goal being to determine antibody concentrations that ensure highly reproducible... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 378 |
SubjectTerms | Animals Antibodies, Monoclonal - chemistry Antibodies, Monoclonal - immunology antibody saturation Biomarkers Biomarkers - analysis CD3 antigen CD3 Complex - immunology flow cytometry Flow Cytometry - methods Fluorescence Fluorescent Dyes - chemistry Humans Immunoglobulin G Immunoglobulin G - immunology Mice Monoclonal antibodies Reagents Robustness Saturation Staining Staining and Labeling - methods Titration Workflow |
Title | A Workflow to Achieve Saturation of Fluorophore‐Conjugated Monoclonal Antibodies for Robust Comparison of Biomarker Expression |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcyto.a.24938 https://www.ncbi.nlm.nih.gov/pubmed/40298242 https://www.proquest.com/docview/3229740778 https://www.proquest.com/docview/3196615437 |
Volume | 107 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BJSQuvB8LpTISHLPN2o6TPa5WXVVIPFRaqZws23HUwhJXuwlQTv0J_EZ-CTNONlCQkOAWKfEjHo_9eTzzDcCzvPKV9CpLKLc2HlCETEzhikRxI3C7mDpbUrzzy1dq_0i-OM6Oe4MbxcJ0_BCDwY00I67XpODGrnd_koa68yaMzRiPD4JifcldizDRwcAeJbI05icjkrFETjnv_d6x-O6vhS_vSH_AzMuoNW47i5ugNx3uvE0-jNvGjt3X37gc__-PbsGNHpGyWTeFbsMVX9-Ba12OyvO7cDFjZFCvluEzawKbuZNT_8mzt0QIGqXKQsUWyzaswtlJWPnvF9_moX7fknmuZLhkBLcMsYG6ObWBnBYZAmV2EGy7bth8yINI9WCrH8lfaMX2vvQeuvU9OFrsHc73kz5tQ-KEmhQk9VJZn5UTUaQ-zxwnzveqdJm3znKjPIU-IG5My6lRKq0QRVSGbkSnygsrxX3YqkPtHwKbeO6Uy2VaZVxaLFuq3GZOiVIqIfJiBM83otNnHTuH7niYuabR1EbH0RzB9kauutfRtcalDA9TaU7VPB1eo3bRlYmpfWjxG1ygEPNJkY_gQTcfhoYksdcjwhlBEqX61x7o-bvD17P4-Ogfv38M1zklHY6mn23Yalatf4JIqLE7cJXLNztx1v8AUYsHFw |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB5BEaIXym9ZKGAkOGabjR0ne1ytulqgLVLZSuVkYsdRS7dxtU2Acuoj9Bl5EmacbKAgISFukRL_xOOxvxmPvwF4mRS2EFbGAeXWRgOFiyBLTRrIKOO4XQyNzum-886unO6LNwfxQZvnlO7CNPwQncONNMOv16Tg5JDe_Mkaas4r18_6aD_w9DrcoKTe3qba6_ijeBz6DGVEMxaIYRS1ke9YfvPX0lf3pD-A5lXc6jeeyRp8XHa5iTc57teV7ptvv7E5_sc_3YHbLShlo2YW3YVrtrwHN5s0lef34WLEyKdezN0XVjk2ModH9rNl74kT1AuWuYJN5rVbuNNDt7DfLy7HrvxUk4cuZ7hqODN3voGyOtKO4hYZYmW253R9VrFxlwqR6sFWTyhkaMG2vrZBuuUD2J9szcbToM3cEBguBykJPpfaxvmAp6FNYhMR7XuRm9hqo6NMWrr9gNAxzIeZlGGBQKLI6FB0KC3Xgj-EldKV9hGwgY2MNIkIizgSGsvmMtGxkTwXkvMk7cGrpezUaUPQoRoq5kjRaKpM-dHswcZSsKpV0zOFqxnaU2FC1bzoXqOC0alJVlpX4ze4RiHsEzzpwXozIbqGBBHYI8jpQeDF-tceqPGH2buRf3z8j98_h1vT2c622n69-_YJrEaUg9h7gjZgpVrU9ikCo0o_85P_B3gSCls |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEYgL78dCASPBMdus7TjZ42rbVXkVVFqpnKz4pRaWeLVNgHLqT-A38kvwONlAQUKCW6TEj3hm7M_j8TcAT3JnHbciSzC3dtigMJ6UhS4SQUsWlouxVgbvO7_aEdv7_PlBdtA53PAuTMsP0Tvc0DLifI0GvjBu4ydpqD6p_bAchu0DK87DBS7SArV6c7enj2JZGhOUIctYwseUdoHvofzGr6XPLkl_4MyzsDWuO7OrIFc9bsNNPgybWg3119_IHP__l67BlQ6SkkmrQ9fhnK1uwMU2SeXJTTidEPSou7n_TGpPJvrwyH6y5C0ygkaxEu_IbN74pV8c-qX9fvpt6qv3DfrnDAlzhtdzHxuo6iPlMWqRBKRMdr1qjmsy7RMhYj2h1Y8YMLQkW1-6EN3qFuzPtvam20mXtyHRTIwKFLsRymZmxIrU5pmmSPrujM6s0oqWwuLdhwAcUzMuhUhdgBGuxCPRsbBMcXYb1ipf2btARpZqoXOeuoxyFcoakatMC2a4YCwvBvB0JTq5aOk5ZEvETCWOpixlHM0BrK_kKjsjPZZhLgu7qTTHah73r4N54ZlJWVnfhG_CDBVAH2f5AO60-tA3xJG-PkCcASRRqn_tgZy-23s9iY_3_vH7R3DpzeZMvny28-I-XKaYgDi6gdZhrV429kFARbV6GFX_B3flCRM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Workflow+to+Achieve+Saturation+of+Fluorophore%E2%80%90Conjugated+Monoclonal+Antibodies+for+Robust+Comparison+of+Biomarker+Expression&rft.jtitle=Cytometry.+Part+A&rft.au=Smith%2C+Natalie&rft.au=McGuire%2C+Helen&rft.au=Fazekas+de+St+Groth%2C+Barbara&rft.date=2025-06-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1552-4922&rft.eissn=1552-4930&rft.volume=107&rft.issue=6&rft.spage=378&rft.epage=389&rft_id=info:doi/10.1002%2Fcyto.a.24938&rft.externalDBID=10.1002%252Fcyto.a.24938&rft.externalDocID=CYTOA24938 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-4922&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-4922&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-4922&client=summon |